deoxyglucose has been researched along with Adenocarcinoma of Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, H; Ambati, CR; Amin, SB; Baseler, L; Chen, J; Chen, TY; DeMayo, FJ; Dhar, SS; Flores, ER; Gu, B; Han, CY; Kumar, M; Lee, MG; Lin, YH; Maitituoheti, M; Muller, FL; Putluri, N; Rai, K; Tang, M | 1 |
| Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
| Liu, Y; Wang, XY; Wu, N; Yang, YK; Zhao, YF | 1 |
| Chen, Y; Gong, Y; Lan, H; Luo, L; Qi, X | 1 |
4 other study(ies) available for deoxyglucose and Adenocarcinoma of Lung
| Article | Year |
|---|---|
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Topics: Adenocarcinoma of Lung; Animals; Antimetabolites; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Deoxyglucose; DNA-Binding Proteins; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Glycolysis; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung Neoplasms; Mice; Mice, Knockout; Mice, Nude; Mutation; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Period Circadian Proteins; Prognosis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Deoxyglucose; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
[miR-181c inhibits glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts].
Topics: 4-Chloro-7-nitrobenzofurazan; Adenocarcinoma; Adenocarcinoma of Lung; Deoxyglucose; Fibroblasts; Glycolysis; Hexokinase; Humans; Lung Neoplasms; MicroRNAs; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Cells, Cultured | 2015 |